Ashfield Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-43,412
Closed -$4.31M 238
2019
Q3
$4.31M Sell
43,412
-536
-1% -$50.9K 0.47% 61
2019
Q2
$4.06M Sell
43,948
-897
-2% -$85.2K 0.43% 67
2019
Q1
$4.23M Buy
44,845
+2,509
+6% +$219K 0.46% 64
2018
Q4
$2.71M Sell
42,336
-4,300
-9% -$317K 0.35% 76
2018
Q3
$4.17M Sell
46,636
-962
-2% -$85K 0.47% 63
2018
Q2
$3.78M Sell
47,598
-2,295
-5% -$191K 0.47% 63
2018
Q1
$4.45M Sell
49,893
-18,411
-27% -$1.77M 0.58% 50
2017
Q4
$7.13M Sell
68,304
-1,391
-2% -$157K 0.92% 33
2017
Q3
$10.2M Sell
69,695
-3,037
-4% -$414K 1.36% 17
2017
Q2
$9.45M Buy
72,732
+192
+0.3% +$23.5K 1.29% 17
2017
Q1
$9.03M Sell
72,540
-52,521
-42% -$6.29M 1.25% 20
2016
Q4
$14.5M Sell
125,061
-27,469
-18% -$3.06M 1.42% 17
2016
Q3
$15.9M Sell
152,530
-14,249
-9% -$1.54M 1.31% 20
2016
Q2
$16.4M Sell
166,779
-33,057
-17% -$3.42M 1.32% 25
2016
Q1
$20M Sell
199,836
-23,373
-10% -$2.41M 1.45% 22
2015
Q4
$26.7M Sell
223,209
-56,358
-20% -$6.52M 1.83% 13
2015
Q3
$30.2M Sell
279,567
-84,241
-23% -$10.5M 1.94% 9
2015
Q2
$42.1M Sell
363,808
-11,361
-3% -$1.3M 2.31% 5
2015
Q1
$43.2M Sell
375,169
-73,751
-16% -$8.81M 2.3% 4
2014
Q4
$50.2M Sell
448,920
-11,095
-2% -$1.17M 2.43% 6
2014
Q3
$43.6M Sell
460,015
-13,546
-3% -$1.22M 2.12% 6
2014
Q2
$40.7M Sell
473,561
-16,511
-3% -$1.26M 1.91% 10
2014
Q1
$34.2M Sell
490,072
-9,938
-2% -$787K 1.65% 20
2013
Q4
$42.2M Sell
500,010
-10,058
-2% -$796K 2.02% 7
2013
Q3
$39.3M Sell
510,068
-34,478
-6% -$2.42M 2.03% 5
2013
Q2
$31.9M Buy
+544,546
New +$32.8M 1.72% 11

Other funds holding CELG

Ashfield Capital Partners's CELG Position: Q4 2019 in Review

Ashfield Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 43,412 shares — an estimated $4.31M sold.

Ashfield Capital Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $50.2M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ashfield Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ashfield Capital Partners sold 43,412 Celgene Corp shares in Q4 2019, an estimated $4.31M.
  • Ashfield Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Ashfield Capital Partners's Celgene Corp position peaked at $50.2M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ashfield Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.